ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$1.96
+0.14 (+7.69%)
As of Feb 8, 2:04 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 90.95M 87.33M 87.17M
Net Income 6.08M 8.20M 6.12M
EPS
Profit Margin 6.7% 9.4% 7.0%
Rev Growth -3.1% +6.5% -4.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 31.50M 37.32M 37.66M
Total Equity 65.25M 74.11M 65.78M
D/E Ratio 0.48 0.50 0.57
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 10.53M 10.19M 12.10M
Free Cash Flow 5.16M 6.96M 5.08M